Disrupted signaling and inhibited regeneration in obese mice with fatty livers: Implications for nonalcoholic fatty liver disease pathophysiology

Hepatology

Volumn 34, Issue 4 I, 2001, Pages 694-706

  Yang, Shi Qi ^a   Mandal, Aloke K ^a   Huang, Jiawen ^a   Diehl, Anna Mae ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); STAT3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INDUCTION; FATTY LIVER; HYPOGLYCEMIA; LIVER CELL; LIVER INJURY; LIVER REGENERATION; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; OBESITY; OXIDATIVE STRESS; PARTIAL HEPATECTOMY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0034812914     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2001.28054     Document Type: Article

References (81)

1. Nonalcoholic fatty liver disease: A spectrum of clinical pathological severity
2. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
3. Liver fibrosis in overweight patients
4. Nonalcoholic steatohepatitis. Mayo Clinic experiences with a hitherto unnamed disease
5. Nonalcoholic steatohepatitis
6. A natural history of nonalcoholic fatty liver: A follow-up study
7. Steatohepatitis: A tale of two "hits"?
8. Liver regeneration
9. Failure of regeneration of the steatotic rat liver: Disruption at two different levels in the regeneration pathway
10. Animal models of hepatic steatosis
11. Tumor necrosis factor alpha induces c-jun during the regenerative response to liver injury
12. Activation of Jun kinase is an early event in hepatic regeneration
13. Immediate-early gene expression differs between regenerating liver, insulin-stimulated H-35 cells, and mitogen-stimulated Balb/c 3T3 cells. Liver-specific induction patterns of gene 33, phosphoenolpyruvate carboxykinase, and the jun, fos, and egr families
14. Novel delayed-early and highly insulin-induced growth response genes
15. Rapid activation of PHF/NF kappa B in hepatocytes, a primary response in the regenerating liver
16. Rapid activation of Stat3DNA binding in liver regeneration
17. Coexistence of C/EBP alpha, beta, growth-induced proteins and DNA synthesis in hepatocytes during liver regeneration. Implications for maintenance of the differentiated state during liver growth
18. Tumor necrosis factor alpha modulates CCAAT/Enhancer binding proteins activities and promotes hepatocyte-specific gene expression during liver regeneration
19. CCAAT enhancer-binding protein beta is required for normal hepatocyte proliferation in mice after partial hepatectomy
20. NF kappa B prevents apoptosis and liver dysfunction during liver regeneration
21. Impaired liver regeneration in inducible nitric oxide synthase-deficient mice
22. Antibodies to tumor necrosis factor alpha inhibit liver regeneration after partial hepatectomy
23. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice
24. Initiation of liver growth by tumor necrosis factor: Deficient liver regeneration in mice lacking type I tumor necrosis factor receptor
25. Mitochondrial adaptations to obesity-related oxidant stress
26. Experimental pathology of liver: Restoration of liver of the white rat following partial surgical removal
27. Circadian transcription of the cholesterol 7 alpha hydroxylase gene may involve the liver-enriched bZIP protein DBP
28. Tumor necrosis factor alpha increases mitochondrial oxidant production and induces expression of uncoupling protein-2 expression in the regenerating mouse liver
29. Metformin reverses nonalcoholic fatty liver disease in obese leptin-deficient mice
30. Single step method of RNA isolation by acid guanidine thiocyanate-phenol-chloroform extraction
31. Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion
32. Effects of alcohol on cytokine-inducible transcription factors
33. The mitogen-activated protein kinase kinase/extracellular signal-regulated kinase cascade activation is a key signalling pathway involved in the regulation of G1 phase progression in proliferating hepatocytes
34. NF-kappaB controls cell growth and differentition through transcriptional regulation of cyclin D1
35. NF-kappa B function in growth control: Regulation of cyclin D1 expression and G0/G1-to-S-phase transition
36. Integration of Rac-dependent regulation of cyclin D1 transcription through a nuclear factor-kappaB-dependent pathway
37. Primary rat hepatocytes express cyclin D1 messenger RNA during their growth cycle and during mitogenic transitions induced by transforming growth factor-alpha
38. Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma
39. Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development, and regeneration
40. pp60 (v-src) induction of cyclin D1 requires collaborative interactions between the extracellular signal-regulated kinases, p38, and Jun kinase pathways. A role for cAMP response element-binding protein and activating transcription factor-2 in pp60 (v-src) signaling in breast cancer cells
41. SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors
42. Inhibitors of cyclin-dependent kinases as anti-cancer therapeutics
43. Structural basis of inhibition of CDK-cyclin complexes by INK4 inhibitors
44. Stat3-dependent induction of p19INK4D by IL-10 contributes to inhibition of macrophage proliferation
45. STAT3-medicated differentiation and survival and of myeloid cell response to granulocyte colony-stimulating factor: Role for the cyclin-dependent kinase inhibitor p27 (Kip1)
46. STAT3 mediates IL-6-induced neuroendocrine differentiation in parostate cancer cells
47. A potential role for p15 (Ink4b) and p57 (Kip2) in liver development
48. Uncoupling: New approaches to an old problem of bioenergetics
49. Liver regeneration: An overview
50. Activation of protein kinase B/Akt is sufficient to repress the glucocorticoid and cAMP induction of phosphoenolpyruvate carboxykinase gene
51. Opiod peptides and alpha-melanocyte-stimulating hormone in genetically obese (ob/ob) mice during development
52. Effects of the obese gene product on body weight regulation in ob/ob mice
53. Leptin inhibits insulin gene transcription and reverses hyperinsulinemia in leptin-deficient ob/ob mice
54. Activation of stress-activated protein kinase by MEKK1 phosphorylation of its activator SEK1
55. Transcriptional regulation of MAP kinases
56. The JUN kinase/stress-activated protein kinase pathway is required for epidermal growth factor stimulation of growth of human A549 lung carcinoma cells
57. SEK1 deficiency reveals mitogen-activated protein kinase cascade cross-regulation and leads to abnormal hepatogenesis
58. Inhibition of c-Jun N-terminal kinase 2 expression suppresses growth and apoptosis of human tumor cells in a p53-dependent manner
59. Ectodomain shedding of TGF-alpha and other transmembrane proteins is induced by receptor tyrosine kinase activation and MAP kinase signaling cascades
60. Extracellular signal-regulated protein kinase/Jun kinase cross-talk underlies vascular endothelial cell growth factor-induced endothelial cell proliferation
61. ATPase switches controlling DNA replication initiation
62. The uncoupling proteins, a review
63. Intracellular ATP levels determine cell death fate by apoptosis or necrosis
64. Tumour necrosis factors receptor associated signaling molecules and their role in activation of apoptosis, JNK and NK-kappa B
65. Prevention of anti-IgM-induced apoptosis accompanying G(1) arrest in B lymphoma cells overexpressing dominant-negative mutant form of c-Jun N-terminal kinase 1
66. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway
67. Akt negatively regulates the cJun N-terminal pathway in PC12 cells
68. NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling
69. Involvement of regulatory and catalytic subunits of phosphoinositide 3-kinase in NF-κB activation
70. Akt suppresses apoptosis by stimulating the transactivation potential of the relA/p65 subunit of NF-kB
71. Her-2/neu blocks tumor necrosis factor-induced apoptosis via the Akt/NF-kB pathway
72. Molecular mapping of the mouse ob mutation
73. Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells
74. Leptin induces proliferation of pancreatic beta cell line MIN6 through activation of mitogen-activated protein kinase
75. Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice
76. Leptin enhances wound re-epithelialization and constitutes a direct function of leptin in skin repair
77. Inhibition of hepatic regeneration in rats by acute and chronic ethanol intoxication
78. Leptin receptor missense mutation in the fatty Zucker rat
79. Chronic ethanol consumption induces the production of tumor necrosis factor-alpha and related cytokines in liver and adipose tissue
80. Insulin-like growth factor-II, phosphatidylinositol 3-kinase, nuclear factor-κB and inducible nitric-oxide synthase define a common myogenic signaling pathway
81. Fatty liver vulnerability to lipopolysaccaride despite NF-κB induction and caspase 3 inhibition